On the scales: Social justice and pluralism in reproductive tourism
By Gina Maranto, Biopolitical Times guest contributor
| 02. 01. 2011
The term “reproductive tourism” first surfaced in Canada in the late 1980s as that country carried out an exhaustive survey of public opinion under the Royal Commission headed by Dr. Patricia Baird. The coinage was used to refer to the prospect that unless the government passed comprehensive national laws, women and couples unable to obtain treatments in their own province would seek them out in another. By 1999, Canadians were using it to talk about women who, when refused high risk procedures there, went to the U.S. instead. Today, borders are being crossed throughout the EU, where member states have quite different codes, among different U.S. states, and internationally.
In some quarters, a concerted effort has been made to rename the practice, giving it a less negative spin as “
cross-border [or transborder] reproductive care.” Some have also hyperbolically framed those who travel outside their own countries for reproductive services as victims of repressive legal systems, “
reproductive exiles” who take on added risks by traveling abroad, because if procedures go awry, they are unlikely to have ready...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...